INDO US BIOTECH
Back to Income Statement
|
INDO US BIOTECH Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹104 Cr | ₹73 Cr | ₹62 Cr | ₹50 Cr | ₹40 Cr |
What is the latest Revenue of INDO US BIOTECH ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹104 Cr |
| Mar2024 | ₹73 Cr |
| Mar2023 | ₹62 Cr |
| Mar2022 | ₹50 Cr |
| Mar2021 | ₹40 Cr |
How is Revenue of INDO US BIOTECH Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹104 Cr | 42.56 | |
| Mar2024 | ₹73 Cr | 17.96 | |
| Mar2023 | ₹62 Cr | 23.36 | |
| Mar2022 | ₹50 Cr | 24.86 | |
| Mar2021 | ₹40 Cr | - | |
Compare Revenue of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹177.9 Cr | -1% | -11.1% | -43.1% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,574.0 Cr | -3.9% | 2.5% | -26.1% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,995.7 Cr | -1.1% | -1.2% | -11.4% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,072.8 Cr | 1.4% | 1.3% | 9.5% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹949.7 Cr | -0.6% | -6.5% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹546.4 Cr | 3.6% | 8% | 10.7% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -1% |
-11.1% |
-43.1% |
| SENSEX | 1% |
2.9% |
-6.1% |
You may also like the below Video Courses